Clinical Trial Update: Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating interleukin-2 in combination with zoledronic acid for kidney cancer; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-03-19